Rev Esp Quimioter 2016, 29(Suppl. 1):26-30

Resistant gram-negative bacteria. Therapeutic approach and risk factors                     

PATRICIA SALGADO, FERNANDO GILSANZ, EMILIO MASEDA          

The rapid spread of multidrug-resistant bacteria has become a serious threat, especially in critical care units, thereby prolonging the hospital stay. Enterobacteriaceae have a high capacity to adapt to any environment. Plasmids are the reason behind their expansion. The choice of empiric therapy for intra-abdominal or urinary infections requires knowledge of the intrinsic microbiological variability of each hospital or critical care unit, as well as the source of infection, safety or antibi-tic toxicity, interaction with other drugs, the dosage regimen and the presence of risk factors. Carbapenems are the drug of choice in the case of suspected infection by ESBL-producing Enterobacteriaceae. The new ceftazidime/avibactam and ceftolozane/tazobactam drugs are opening up promising new horizons in the treatment of multidrug-resistant Enterobacteriaceae.

Rev Esp Quimioter 2016; 29(Suppl. 1):26-30 [pdf]